Download App

Log in to access Online Inquiry
Company Overview More
Kingsley Biotechnology Co., Ltd. is a Hong Kong investment holding company mainly engaged in bioscience research and related business. The company operates through four major divisions. The Life Sciences Research Services Division includes gene and peptide synthesis, DNA and nucleic acid primer synthesis, deoxyribonucleic acid sequencing, customized antibody services, protein expression and stable cell line production. The preclinical drug development service division includes protein and antibody engineering, in vitro efficacy research and in vivo efficacy research. The Life Science Research Catalog Product Division provides antibodies, recombinant proteins, protein separation and analysis instruments, molecular biological reagents, peptides, biochemical products and stable cell lines. Industrial synthetic biological products division develops and produces industrial enzymes.
CEO: Jiange Meng
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

01548 Genscript Biotech Corporation
22.350+1.200+5.67%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
39.73% 44.36M 44.28% 34.89M 92.56% 31.75M 64.21% 24.18M
Accounts receivable
0.42% 142.35M 46.55% 92.64M 94% 141.75M 28.02% 63.21M
Advance deposits and other receivables
9.81% 36.05M -23.75% 28.78M 3.84% 32.83M 68.41% 37.75M
Cash and equivalents
87.74% 1.18B 35.51% 957.62M 149.23% 629.06M 149.2% 706.69M
Fixed time deposit-current assets
39.52% 190.09M 23.31% 213.39M -8.37% 136.25M 22.68% 173.05M
Secured deposit
-80.67% 1.44M -19% 2.55M 668.62% 7.47M 1607.61% 3.14M
Financial assets at fair value-current assets
-62.36% 2.21M -96.67% 1.64M -76.94% 5.87M -38.15% 49.43M
Special items of current assets
393.41% 40.49M 1719.96% 39.84M 52.66% 8.21M -- 2.19M
Total current assets
64.92% 1.64B 29.42% 1.37B 79.26% 993.17M 79.22% 1.06B
Non-current assets
Property, plant and equipment
27.42% 439.89M 41.16% 395.25M 46.29% 345.22M 43.93% 280M
Investment property
-10.92% 6.88M -3.4% 7.22M 3.82% 7.73M -1.19% 7.47M
Advance payment
213.44% 18.51M 55.86% 9.25M -31.21% 5.91M -74.97% 5.94M
Associated company interest
-3.35% 3.32M 32.55% 3.32M 31.28% 3.43M -16.11% 2.5M
Fixed time deposit-non-current assets
-- 4.71M -- -- -- -- -- --
Financial assets at fair value-non-current assets
-1.05% 10.44M 101.87% 11.24M 126.16% 10.56M 37.11% 5.57M
Intangible assets
1.55% 26.42M -0.33% 27.26M 2.11% 26.02M 38.7% 27.35M
Goodwill
0.25% 14.15M -7.08% 14.13M -7.41% 14.12M -0.5% 15.21M
Deferred tax assets
37.49% 5.09M -21.85% 3.09M -35.06% 3.7M -77.51% 3.95M
Other illiquid assets
76.48% 6.25M -- 4.22M -- 3.54M -- --
Special items of non-current assets
73.87% 59.15M 29.74% 41.74M 14.76% 34.02M 510.26% 32.17M
Total non-current assets
30.95% 594.81M 35.92% 516.72M 35.44% 454.23M 30.78% 380.17M
Total assets
54.26% 2.23B 31.13% 1.89B 62.74% 1.45B 63.25% 1.44B
Liabilities
Current liabilities
Accounts payable
29.09% 30.18M 19.84% 27.24M 32.61% 23.38M 63.16% 22.73M
Tax payable
76.56% 6.24M 47.71% 5.25M 24.1% 3.53M -39.04% 3.56M
Dividend payable
-- -- -- -- -- -- -- 14.88M
Other payables and accrued expenses
26.33% 213.47M 54.99% 192.08M 35.15% 168.98M 47.31% 123.93M
Bank loans and overdrafts
-98.83% 521K -57.69% 20.55M 162.48% 44.64M 183.13% 48.56M
Financial lease liabilities-current liabilities
190.19% 7.51M 101.7% 4.75M 46.3% 2.59M 70.38% 2.35M
Special items of current liabilities
143.48% 206.46M 173.52% 171.42M 40.81% 84.79M 52.45% 62.67M
Total current liabilities
41.61% 464.37M 51.17% 421.29M 46.06% 327.91M 70.41% 278.69M
Net current assets
76.41% 1.17B 21.65% 950.05M 101.88% 665.26M 82.59% 780.96M
Total assets less current liabilities
57.96% 1.77B 26.32% 1.47B 68.37% 1.12B 61.62% 1.16B
Non-current liabilities
Long-term bank loan
9508.73% 121.07M 1124.88% 18.21M -27.92% 1.26M -27.11% 1.49M
Financial lease liabilities-non-current liabilities
319.91% 27.35M 101.36% 12.3M 80.52% 6.51M 48.56% 6.11M
Deferred tax liability
9.96% 7.73M 27.33% 9.8M 25.94% 7.03M 44.45% 7.7M
Other non-current liabilities
-28.52% 396K -- 554K -- 554K -- --
Special items of non-current liabilities
79.83% 518.9M 2.37% 266.56M 2.44% 288.55M 5.02% 260.38M
Total non-current liabilities
122.26% 675.45M 11.52% 307.43M 3.86% 303.9M 6.27% 275.67M
Total liabilities
80.4% 1.14B 31.45% 728.71M 22.18% 631.82M 31.07% 554.36M
Total assets less total liabilities
34.01% 1.09B 30.93% 1.16B 119.07% 815.59M 92.91% 885.45M
Total equity and non-current liabilities
57.96% 1.77B 26.32% 1.47B 68.37% 1.12B 61.62% 1.16B
Equity
Share capital
7.27% 2.1M 8.5% 2.08M 3.99% 1.95M 3.12% 1.92M
Reserve
-2.52% 893.41M 6.93% 1.03B 135.78% 916.46M 111.02% 958.68M
Legal reserve
-2.52% 893.41M 6.93% 1.03B 135.78% 916.46M 111.02% 958.68M
Special items of shareholders' rights and interests
5.74% -15.75M 5.26% -16.33M -114.97% -16.71M -658.87% -17.23M
Shareholders' Equity
-2.43% 879.75M 7.16% 1.01B 135.55% 901.71M 107.83% 943.36M
Non-controlling interest
347.58% 213.2M 356.39% 148.48M -719.66% -86.11M -1235.94% -57.91M
Total equity
34.01% 1.09B 30.93% 1.16B 119.07% 815.59M 92.91% 885.45M
Total equity and total liabilities
54.26% 2.23B 31.13% 1.89B 62.74% 1.45B 63.25% 1.44B
Currency Unit
USDUSDUSDUSD
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Ernst & Young accounting firm--Ernst & Young accounting firm--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%